VSTM
Price
$4.74
Change
-$0.07 (-1.46%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
264.31M
WVE
Price
$7.93
Change
+$0.23 (+2.99%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
1.2B
20 days until earnings call
Interact to see
Advertisement

VSTM vs WVE

Header iconVSTM vs WVE Comparison
Open Charts VSTM vs WVEBanner chart's image
Verastem
Price$4.74
Change-$0.07 (-1.46%)
Volume$41.81K
Capitalization264.31M
Wave Life Sciences
Price$7.93
Change+$0.23 (+2.99%)
Volume$152.91K
Capitalization1.2B
VSTM vs WVE Comparison Chart in %
Loading...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VSTM vs. WVE commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSTM is a StrongBuy and WVE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (VSTM: $4.74 vs. WVE: $7.95)
Brand notoriety: VSTM and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VSTM: 64% vs. WVE: 212%
Market capitalization -- VSTM: $264.31M vs. WVE: $1.2B
VSTM [@Biotechnology] is valued at $264.31M. WVE’s [@Biotechnology] market capitalization is $1.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VSTM’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • VSTM’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, WVE is a better buy in the long-term than VSTM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VSTM’s TA Score shows that 6 TA indicator(s) are bullish while WVE’s TA Score has 5 bullish TA indicator(s).

  • VSTM’s TA Score: 6 bullish, 3 bearish.
  • WVE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VSTM is a better buy in the short-term than WVE.

Price Growth

VSTM (@Biotechnology) experienced а -1.25% price change this week, while WVE (@Biotechnology) price change was +14.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

VSTM is expected to report earnings on May 13, 2025.

WVE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.2B) has a higher market cap than VSTM($264M). VSTM YTD gains are higher at: -8.317 vs. WVE (-35.732). WVE has higher annual earnings (EBITDA): -117.1M vs. VSTM (-145.04M). WVE has more cash in the bank: 243M vs. VSTM (118M). WVE has less debt than VSTM: WVE (23.6M) vs VSTM (76.8M). WVE has higher revenues than VSTM: WVE (105M) vs VSTM (10M).
VSTMWVEVSTM / WVE
Capitalization264M1.2B22%
EBITDA-145.04M-117.1M124%
Gain YTD-8.317-35.73223%
P/E RatioN/AN/A-
Revenue10M105M10%
Total Cash118M243M49%
Total Debt76.8M23.6M325%
FUNDAMENTALS RATINGS
VSTM vs WVE: Fundamental Ratings
VSTM
WVE
OUTLOOK RATING
1..100
5315
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
6346
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WVE's Valuation (56) in the Biotechnology industry is in the same range as VSTM (80). This means that WVE’s stock grew similarly to VSTM’s over the last 12 months.

WVE's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VSTM (100). This means that WVE’s stock grew similarly to VSTM’s over the last 12 months.

WVE's SMR Rating (98) in the Biotechnology industry is in the same range as VSTM (99). This means that WVE’s stock grew similarly to VSTM’s over the last 12 months.

WVE's Price Growth Rating (46) in the Biotechnology industry is in the same range as VSTM (63). This means that WVE’s stock grew similarly to VSTM’s over the last 12 months.

WVE's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VSTM (100). This means that WVE’s stock grew similarly to VSTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VSTMWVE
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 11 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFEIX40.63N/A
N/A
JPMorgan Europe Dynamic L
FOSKX75.05N/A
N/A
Fidelity Overseas K
FMPOX29.81N/A
N/A
Fidelity Advisor Mid Cap Value I
WSMVX26.72N/A
N/A
Wilshire Small Company Value Instl
BLYYX35.07-0.21
-0.60%
American Beacon Man Lg Cp Growth Y

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with ZLDAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then ZLDAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
-1.46%
ZLDAF - VSTM
47%
Loosely correlated
N/A
SNSE - VSTM
47%
Loosely correlated
-0.55%
NKTX - VSTM
41%
Loosely correlated
-0.55%
IPSC - VSTM
41%
Loosely correlated
-1.20%
SYRE - VSTM
40%
Loosely correlated
-3.56%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
+3.25%
PRQR - WVE
61%
Loosely correlated
+2.61%
KRRO - WVE
53%
Loosely correlated
-7.68%
OCUL - WVE
47%
Loosely correlated
+2.97%
ATNF - WVE
44%
Loosely correlated
+5.26%
KYMR - WVE
40%
Loosely correlated
+0.07%
More